BACKGROUND: Despite being associated with worse prognosis in patients with COVID-19, systematic determination of myocardial injury is not recommended. The aim of the study was to study the effect of myocardial injury assessment on risk stratification of COVID-19 patients. METHODS: Seven hundred seven consecutive adult patients admitted to a large tertiary hospital with confirmed COVID-19 were included. Demographic data, comorbidities, laboratory results and clinical outcomes were recorded. Charlson comorbidity index (CCI) was calculated in order to quantify the degree of comorbidities. Independent association of cardiac troponin I (cTnI) increase with outcomes was evaluated by multivariate regression analyses and area under curve. In addition, propensity-score matching was performed to assemble a cohort of patients with similar baseline characteristics. RESULTS: In the matched cohort (mean age 66.76 ± 15.7 years, 37.3% females), cTnI increase above the upper limit was present in 20.9% of the population and was associated with worse clinical outcomes, including all-cause mortality within 30 days (45.1% vs. 23.2%; p = 0.005). The addition of cTnI to a multivariate prediction model showed a significant improvement in the area under the time-dependent receiver operating characteristic curve (0.775 vs. 0.756, DC-statistic = 0.019; 95% confidence interval 0.001-0.037). Use of renin-angiotensin-aldosterone system inhibitors was not associated with mortality after adjusting by baseline risk factors. CONCLUSIONS: Myocardial injury is independently associated with adverse outcomes irrespective of baseline comorbidities and its addition to multivariate regression models significantly improves their performance in predicting mortality. The determination of myocardial injury biomarkers on hospital admission and its combination with CCI can classify patients in three risk groups (high, intermediate and low) with a clearly distinct 30-day mortality.
BACKGROUND: Despite being associated with worse prognosis in patients with COVID-19, systematic determination of myocardial injury is not recommended. The aim of the study was to study the effect of myocardial injury assessment on risk stratification of COVID-19patients. METHODS: Seven hundred seven consecutive adult patients admitted to a large tertiary hospital with confirmed COVID-19 were included. Demographic data, comorbidities, laboratory results and clinical outcomes were recorded. Charlson comorbidity index (CCI) was calculated in order to quantify the degree of comorbidities. Independent association of cardiac troponin I (cTnI) increase with outcomes was evaluated by multivariate regression analyses and area under curve. In addition, propensity-score matching was performed to assemble a cohort of patients with similar baseline characteristics. RESULTS: In the matched cohort (mean age 66.76 ± 15.7 years, 37.3% females), cTnI increase above the upper limit was present in 20.9% of the population and was associated with worse clinical outcomes, including all-cause mortality within 30 days (45.1% vs. 23.2%; p = 0.005). The addition of cTnI to a multivariate prediction model showed a significant improvement in the area under the time-dependent receiver operating characteristic curve (0.775 vs. 0.756, DC-statistic = 0.019; 95% confidence interval 0.001-0.037). Use of renin-angiotensin-aldosterone system inhibitors was not associated with mortality after adjusting by baseline risk factors. CONCLUSIONS:Myocardial injury is independently associated with adverse outcomes irrespective of baseline comorbidities and its addition to multivariate regression models significantly improves their performance in predicting mortality. The determination of myocardial injury biomarkers on hospital admission and its combination with CCI can classify patients in three risk groups (high, intermediate and low) with a clearly distinct 30-day mortality.
Authors: Maciej M Kowalik; Piotr Trzonkowski; Magdalena Łasińska-Kowara; Andrzej Mital; Tomasz Smiatacz; Miłosz Jaguszewski Journal: Cardiol J Date: 2020-05-07 Impact factor: 2.737
Authors: Joshua Geleris; Yifei Sun; Jonathan Platt; Jason Zucker; Matthew Baldwin; George Hripcsak; Angelena Labella; Daniel K Manson; Christine Kubin; R Graham Barr; Magdalena E Sobieszczyk; Neil W Schluger Journal: N Engl J Med Date: 2020-05-07 Impact factor: 91.245
Authors: Elissa Driggin; Mahesh V Madhavan; Behnood Bikdeli; Taylor Chuich; Justin Laracy; Giuseppe Biondi-Zoccai; Tyler S Brown; Caroline Der Nigoghossian; David A Zidar; Jennifer Haythe; Daniel Brodie; Joshua A Beckman; Ajay J Kirtane; Gregg W Stone; Harlan M Krumholz; Sahil A Parikh Journal: J Am Coll Cardiol Date: 2020-03-19 Impact factor: 24.094
Authors: Alaa Hasan Alali; Mustafa Samir Smaisem; Ahmed Mohammed Alsheikh; Aljohara Abdullah Alshareef; Fatema Samir Smaisem; Batool Wael Alnahar; Amal Khalil Hassouneh; Jaffar A Al-Tawfiq; Ziad A Memish Journal: Infez Med Date: 2021-09-10
Authors: Jie Yang; Xuelian Liao; Wanhong Yin; Bo Wang; Jirong Yue; Lang Bai; Dan Liu; Ting Zhu; Zhixin Huang; Yan Kang Journal: Am J Emerg Med Date: 2020-10-13 Impact factor: 4.093
Authors: Yan Ma; Dong Shan Zhu; Ren Bo Chen; Nan Nan Shi; Si Hong Liu; Yi Pin Fan; Gui Hui Wu; Pu Ye Yang; Jiang Feng Bai; Hong Chen; Li Ying Chen; Qiao Feng; Tuan Mao Guo; Yong Hou; Gui Fen Hu; Xiao Mei Hu; Yun Hong Hu; Jin Huang; Qiu Hua Huang; Shao Zhen Huang; Liang Ji; Hai Hao Jin; Xiao Lei; Chun Yan Li; Min Qing Li; Qun Tang Li; Xian Yong Li; Hong De Liu; Jin Ping Liu; Zhang Liu; Yu Ting Ma; Ya Mao; Liu Fen Mo; Hui Na; Jing Wei Wang; Fang Li Song; Sheng Sun; Dong Ting Wang; Ming Xuan Wang; Xiao Yan Wang; Yin Zhen Wang; Yu Dong Wang; Wei Wu; Lan Ping Wu; Yan Hua Xiao; Hai Jun Xie; Hong Ming Xu; Shou Fang Xu; Rui Xia Xue; Chun Yang; Kai Jun Yang; Sheng Li Yuan; Gong Qi Zhang; Jin Bo Zhang; Lin Song Zhang; Shu Sen Zhao; Wan Ying Zhao; Kai Zheng; Ying Chun Zhou; Jun Teng Zhu; Tian Qing Zhu; Hua Min Zhang; Yan Ping Wang; Yong Yan Wang Journal: Biomed Environ Sci Date: 2020-12-20 Impact factor: 3.118
Authors: William Galanter; Jorge Mario Rodríguez-Fernández; Kevin Chow; Samuel Harford; Karl M Kochendorfer; Maryam Pishgar; Julian Theis; John Zulueta; Houshang Darabi Journal: BMC Med Inform Decis Mak Date: 2021-07-24 Impact factor: 2.796
Authors: Tejaswini Mishra; Meng Wang; Ahmed A Metwally; Gireesh K Bogu; Andrew W Brooks; Amir Bahmani; Arash Alavi; Alessandra Celli; Emily Higgs; Orit Dagan-Rosenfeld; Bethany Fay; Susan Kirkpatrick; Ryan Kellogg; Michelle Gibson; Tao Wang; Erika M Hunting; Petra Mamic; Ariel B Ganz; Benjamin Rolnik; Xiao Li; Michael P Snyder Journal: Nat Biomed Eng Date: 2020-11-18 Impact factor: 29.234
Authors: Jorge Sanz-Sánchez; Dimitrios A Vrachatis; Bernhard Reimers; Spyridon G Deftereos; Marinos Kallikourdis; Marco Vicenzi; George Giannopoulos; Sotiria G Giotaki; Dimitrios Tousoulis; Giuseppe Ferrante; Gianluigi Condorelli; Giulio G Stefanini Journal: Hellenic J Cardiol Date: 2020-08-08